Question follow-through · 24600
Trastuzumab Deruxtecan
To ask the Secretary of State for Health and Social Care, what assessment her department has made on the availability of NHS Funding for the breast cancer drug Enhertu in England and Wales, in the context of treatment available to Scottish patients.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 28 Aug 2026
- Target answer date
- 2 Sept 2026
- Answer
- 15 Sept 2026 · 18 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
28 Aug 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment her department has made on the availability of NHS Funding for the breast cancer drug Enhertu in England and Wales, in the context of treatment available to Scottish patients.
2 Sept 2026
Target answer date
Date supplied by the official written-questions record.
15 Sept 2026
Answer published
I refer the Hon. Members to the answer provided on 17 July to Question 17825.
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.